What is Neurable?
Neurable Inc., based in Massachusetts, is at the forefront of neurotechnology, specializing in the development of AI-driven tools for brain signal translation and BCI. Leveraging patented signal processing techniques refined through extensive research and a team of leading scientists and product experts, Neurable's AI platform facilitates high-performance BCI integration into common devices. The company's commitment is to foster a world where innovative neurotechnology empowers individuals to transcend physical and cognitive barriers, marking a significant advancement in human-computer interaction.
How much funding has Neurable raised?
Neurable has raised a total of $56.1M across 5 funding rounds:
Angel/Seed
$2M
Series A
$6M
Debt
$150K
Other Financing Round
$13M
Series A
$35M
Angel/Seed (2016): $2M with participation from NXT Ventures, Point Judith Capital, and The Kraft Group
Series A (2019): $6M led by Point Judith Capital, M Ventures, Loup Ventures, Innospark Ventures, and Zell Lurie Commercialization Fund
Debt (2020): $150K supported by PPP
Other Financing Round (2024): $13M featuring Pace Ventures, Metaplanet, and Ultratech Capital Partners
Series A (2025): $35M, investors not publicly disclosed
Key Investors in Neurable
Pace Ventures
Pace Ventures is an investment firm focused on driving progress through innovation, utilizing hackathons, incubators, and accelerators. They collaborate with startups, corporates, and agencies to achieve client goals, emphasizing openness and partnership.
Metaplanet
Metaplanet is an early-stage investment firm backing mission-driven founders in deep technologies that positively impact society. They prioritize long-term investments in sectors like AI and life sciences, offering a founder-friendly approach.
Ultratech Capital Partners
Ultratech Capital Partners invests in early-stage companies developing 'dual use' technologies critical for national security and addressing global challenges, with a focus on AI, cybersecurity, and semiconductors.
What's next for Neurable?
The substantial enterprise-level backing Neurable has received, particularly the recent strategic investment, positions the company for accelerated growth and market expansion. This infusion of capital is expected to fuel further research and development in AI-powered brain signal translation, enhance the capabilities of their BCI platform, and broaden the application of their technology across various everyday devices. The company's trajectory suggests a focus on scaling operations and solidifying its position as a leader in the burgeoning neurotechnology sector, potentially leading to new partnerships and product rollouts aimed at democratizing access to advanced BCI solutions.
See full Neurable company page
